Kolling at the centre of life-changing health research As research capabilities expand across northern Sydney, that growth will be supported by the expertise and experience at the Kolling Institute.
Located next to Royal North Shore Hospital, the Kolling has been at the forefront of scientific discovery for more than 100 years. It is the oldest health research institute in the state, and home to Australia’s first diabetic clinic. Today, researchers are pursuing innovations from discovery science to impactful, potentially life-changing projects. Their work is extending our understanding of complex health conditions, offering new treatments and improving community wellbeing at every age. At the Kolling Institute, investigators consistently produce world-leading research into some of our most significant health challenges, including heart and kidney disease, chronic pain and neurological conditions, as well as cancer, musculoskeletal and age-related conditions. Current research projects are set to help transform care for knee osteoarthritis, rare cancers, pain and diabetes, while others are shedding light on the genetic factors driving heart disease and disabling Meniere’s disease. A large share of investigators are ranked in the top two per cent of global experts in their field; remarkably, this is not limited to a few research areas, but reaches right across the institute. The depth of experience places the institute in a privileged position. It is an important year for the Kolling, as it launches its refreshed research strategy, delivering a robust strategic framework for the next five years. This will ensure researchers are in the best position to progress their crucial work, and extend access to the very latest, high-value care. The forward-looking strategy comes after many months of work behind the scenes, with input from researchers, clinicians, and scientists as well as patients and those with lived experience, administrators and industry partners. A key part of the strategic direction will see cancer established as a focused area of research. The Kolling will draw on its strength in this field to foster innovative research that improves cancer
treatments, survival and outcomes, not just across our district but nationally and worldwide. Our research success relies on our strong partnerships, and the refreshed strategy will increase efforts to expand local, national and international collaborations. Community input and engagement will be another crucial part of our research impact. As a joint venture partnership, the Kolling Institute is supported by the resources and expertise of the University of Sydney and the Northern Sydney Local Health District. This places investigators in a strong position to drive significant change in the delivery of healthcare. Researchers are well placed to maximise the impact of their work given the combined efforts of the local health district, NSW Health, the Kolling and the university. Driven by a shared belief that research is the cornerstone of high-quality healthcare, each organisation is working towards a common goal of sustained research growth and success. Our Kolling Institute researchers are proud to be part of the collaboration, and dedicated to building on their remarkable legacy, offering hope, and better long-term health outcomes.
Professor James Elliott Academic Director The Kolling Institute
17
Made with FlippingBook - professional solution for displaying marketing and sales documents online